Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection

Journal of Infectious Diseases

Volumn 182, Issue 6, 2000, Pages 1636-1642

  van Soolingen, Dick ^a   de Haas, Petra E W ^a   van Doorn, H Rogier ^b   Kuijper, Ed ^b   Rinder, Heinz ^c   Borgdorff, Martien W ^d  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF MUNICH   (Germany)

^d KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; CD4 ANTIGEN; EFAVIRENZ; HYDROXYUREA; INDINAVIR; LAMIVUDINE; NELFINAVIR; SAQUINAVIR; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; LATENT VIRUS INFECTION; MALE; PRIORITY JOURNAL; SEROCONVERSION; T LYMPHOCYTE; VIRUS LATENCY;

ACUTE DISEASE; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; TIME FACTORS; VIRUS LATENCY;

EID: 0033681160     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/317615     Document Type: Article

References (24)

1. Fate of HIV-1-infected T cells in vivo: Rates of transition to stable latency
2. Quantitation of latent tissue reservoirs and total body load in HIV-1 infection
3. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
4. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
5. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
6. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
7. Reservoirs for HIV-1 mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy
8. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
9. Characterization of chemokine receptor utilization of viruses in the latent reservoir for HIV-1
10. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes
11. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection
12. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro
13. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, viral generation time
14. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
15. Viral dynamics in human immunodeficiency virus type 1 infection
16. Kinetics of response in lymphoid tissue to antiretroviral therapy of HIV-1 infection
17. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
18. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection
19. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection
20. New strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes
21. + T cells during primary HIV-1 infection
22. Decay characteristics of HIV-1-infected compartments during combination therapy
23. + T-cell subpopulations
24. Persistence of HIV-1 transcription in peripheral blood mononuclear cells in patients receiving potent antiretroviral therapy